Ewing sarcoma

1) Disease Description (Causes and Symptoms)

• Summary of definition: Ewing sarcoma is a malignant small-cell tumor that occurs mainly in the bones (or soft tissues) of children and adolescents. It is the second most common pediatric bone tumor after osteosarcoma. It mainly occurs in the diaphysis of long bones (such as the femur), as well as the pelvis and ribs.
• Causes/pathophysiology:
  • It is usually caused by a specific chromosomal translocation (in approximately 85% of cases, the EWSR1-FLI1 fusion gene resulting from t(11;22)(q24;q12) is observed). This fusion protein is involved in tumor development.
  • In rare cases, radiation exposure and other factors may be associated, but most cases are caused by genetic and molecular abnormalities.
  • Histologically, it consists of small round blue cells and shows features of the neuroectodermal lineage.
• Main symptoms:
  • Localized pain (especially tenderness), swelling, or a palpable mass
  • Warmth in the affected area and fever (systemic fever may also occur)
  • Functional limitations (such as difficulty walking) and possible fracture (pathologic fracture)

2) Treatment Methods and Precautions

• Standard treatment (multidisciplinary approach):
  • Systemic chemotherapy (combination anticancer therapy) is the mainstay of treatment: representative combination regimens include VDC/IE (vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide + etoposide), among others.
  • Local treatment: surgery (limb-sparing surgery whenever possible) or radiation therapy (used for unresectable tumors, residual tumors, tumors at surgical margins, etc.). The choice between surgery and radiation depends on the tumor’s location, size, and degree of invasion into surrounding structures.
  • In metastatic cases, in addition to standard anticancer therapy, clinical trials and high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation may be considered (the evidence and indications depend on the patient’s condition and the guidelines of each institution).
• Important tests during diagnosis and treatment:
  • Imaging: X-ray, MRI (assessment of local invasion), chest CT (assessment of lung metastases), bone scan or PET-CT (assessment of systemic metastases), bone marrow examination (confirmation of bone marrow metastases)
  • Biopsy: pathology, immunohistochemistry (IHC), and molecular diagnosis (confirmation of the EWSR1 fusion gene using FISH, RT-PCR, etc.)
• Side effects, complications, and precautions:
  • Treatment-related: bone marrow suppression (risk of infection), vomiting, hair loss, nephrotoxicity (ifosfamide), cardiotoxicity (doxorubicin — cumulative dose management and cardiac function monitoring are necessary), risk of infertility, and risk of secondary malignancies
  • Surgery- and radiation-related: wound infection, loss of function, radiation-induced growth disturbance (in children), and radiation tissue damage
  • Infection control during treatment (visit a medical institution immediately if fever occurs) and starting treatment without delay are important
• Lifestyle management:
  • Get sufficient rest and prevent infection during treatment (handwashing and avoiding crowded places)
  • Long-term complications after anticancer therapy and radiation (including cardiac, renal, pulmonary, and reproductive function complications) require monitoring — counseling on fertility preservation (sperm or egg preservation) is recommended

3) Checklist Before an Outpatient Visit (Including Items to Bring and Example Questions)

• Items to bring (recommended):
  • A list of all currently used medications (including prescriptions, OTC medicines, and supplements)
  • Previous test results (imaging CDs and medical reports) and pathology reports (the originals, if possible)
  • A record of symptom changes (degree of pain, frequency of fever, changes in mass size, etc.), weight changes, and dietary status
  • Records of previous treatment (surgery, radiation, and anticancer therapy) and allergy history
  • Family history (whether there are similar cancer conditions), possibility of pregnancy, or plans for pregnancy (for women)
• Information to briefly tell the doctor during the outpatient visit:
  • When the symptoms began and how they have progressed (pain, mass size, and fever)
  • Any recent infections or history of fever
  • Current medications and experiences of side effects

4) Examples of General Questions to Ask the Doctor

• "What is the recommended standard treatment plan (chemotherapy, surgery, and radiation)? How long is the expected treatment period?"
• "What are the major short-term and long-term side effects of this treatment? How can the side effects be reduced?"
• "How will long-term follow-up be conducted after treatment? What tests will I need, and how often?"
• "Is there a risk related to fertility (infertility)? Should I consider fertility preservation methods?"

5) Examples of Disease-Specific Questions

• "Was EWSR1-FLI1 or another fusion gene identified in the pathology examination? How will the molecular genetic results affect the treatment plan?"
• "Metastases to the lungs or bone marrow, for example, were identified at diagnosis. What is the treatment strategy based on the metastatic status (e.g., high-dose chemotherapy + hematopoietic stem cell transplantation)?"

Additional information:

• For Ewing sarcoma, a multidisciplinary approach is important from a treatment perspective, involving pediatric and adolescent oncologists, orthopedic surgeons (cancer surgery), radiation oncologists, radiologists, pathologists, and other specialists in joint discussions.
• For questions or emergency symptoms (high fever, difficulty breathing, sudden severe pain, bleeding, etc.), visit a medical institution immediately for evaluation.